Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
7,341 total articles
Michael Wayne Domino Jr., President of the DTR Division at Drilling Tools International Corp (DTI), sold 997 shares at $4.00 on March 30, 2026, for $3,988. Following the sale he retains direct ownership of 1,449,002 shares and a mix of restricted stock units, performance stock units and option grants. The transaction was executed under a Rule 10b5-…
William W. Sheehan II, Executive Vice President and Chief Financial Officer of Ross Stores, INC. (NASDAQ:ROST), sold 4,883 shares of the company on March 26, 2026, at a weighted average price of $216.9501, totaling $1,059,367. The transaction occurred as the stock traded close to its 52-week high, following a 68% gain over the prior 12 months. The …
ServisFirst Bancshares director Christopher J. Mettler sold 15,215 shares of the bank's common stock in several transactions dated between November 21, 2024 and December 24, 2024, netting roughly $1.36 million. The trades occurred at prices spanning $85.54 to $96.25 per share. Following the disposals, Mettler holds 3,505 shares directly, which incl…
David A. Duffield, who holds roughly a 10% stake in Workday, Inc., sold 107,500 shares of Class A common stock on March 26, 2026, in multiple transactions totaling $13.8 million. The sale came the same day he converted 107,500 Class B shares into Class A shares. The transactions, company filings show, occurred at prices from $127.8456 to $130.1836.…
A director of Kestra Medical Technologies, LTD. increased his stake by purchasing 10,000 shares valued at $199,800, with transaction prices ranging from $19.82 to $20.02. The trade comes as the stock trades lower year-to-date at $18.33. Kestra reported a fiscal third-quarter EPS shortfall while posting revenue ahead of expectations, and analysts fr…
Hudson Pacific Properties director Ferguson T Ritson purchased 16,000 shares on March 30, 2026, paying $5.97 per share for a total of $95,520. The transaction, adjusted for a one-for-seven reverse stock split effected December 2, 2025, brings his direct ownership to 18,997 shares. The trade comes while HPP shares trade close to a 52-week low and af…
Brian R. Dowd, Senior Vice President at Granite Construction Inc (NYSE:GVA), disposed of 6,075 shares on March 27, 2026, in two automated transactions totaling about $726,124. The sales were carried out under a Rule 10b5-1 trading plan adopted December 4, 2025. Granite reported fourth-quarter 2025 earnings and revenue that exceeded analyst forecast…
Granite Construction Inc CFO Staci M. Woolsey sold 3,501 shares on March 27, 2026, for $118.58 each, generating $415,148 in proceeds under a pre-arranged Rule 10b5-1 trading plan. The stock has risen 56% over the past year and is trading modestly above an InvestingPro-derived Fair Value estimate. Separately, Granite reported stronger-than-expected …
Andrea Botta, a director at Cheniere Energy, sold 5,000 shares of common stock on March 27, 2026, at $296.47 per share, generating proceeds of $1.48 million. The sale occurred while the stock was trading close to a 52-week high and up 51% year-to-date. Cheniere reported a consolidated adjusted EBITDA of $2 billion and net income of $2.3 billion for…
Neurogene Inc. President and Chief Financial Officer Christine Mikail Cvijic sold 2,558 shares on March 26, 2026, for roughly $55,315 to meet tax withholding obligations tied to RSU vesting. The sale was mandatory under the vesting terms and was disclosed in a Form 4 filing. Following the transaction Cvijic directly holds 103,240 shares, including …
GeneDx Holdings Corp CFO Kevin Feeley sold 7,718 Class A shares on March 26, 2026, generating about $557,051 in proceeds. The sales coincided with a 17% drop in the stock over the preceding week. Feeley also exercised restricted stock units the same day for 16,250 shares at no cost and now directly holds 34,580 shares. The company reported strong f…
Solas Capital Management, together with Frederick Tucker Golden, sold a combined 74,425 shares of Epsilon Energy Ltd. (NASDAQ: EPSN) between March 26 and March 30, 2026, generating proceeds of $462,333. The transactions took place in three tranches at prices between $6.17 and $6.25. The company’s stock trades at $6.36 and has risen 38.6% year-to-da…
Anatol Feygin, Cheniere Energy's Executive Vice President and Chief Commercial Officer, sold 40,432 shares on March 26, 2026, in two block transactions totaling $11,764,815, according to an SEC Form 4. The filing cites diversification and tax planning as the rationale. Cheniere recently reported consolidated adjusted EBITDA of $2.0 billion and net …
Stephen M. Bloch, a director at Liquidia Corp (NASDAQ:LQDA), completed four sales of the company's common stock on March 26 and March 27, 2026, totaling $2.53 million. The transactions ranged in price from $35.4214 to $37.2183. The moves coincide with recent company results showing robust Yutrepia revenue but an earnings per share outcome that miss…
Cheniere Energy executive Sean N. Markowitz reported the sale of 22,246 shares on March 26, 2026, in a Form 4 filed with the SEC. The two trades totaled roughly $6.4 million. The transactions occurred while the stock trades close to its 52-week high and after a quarter that produced strong adjusted EBITDA and net income figures for the company.
Carol N. Brown, a director at SL Green Realty Corp. (NYSE: SLG), sold all 5,004 of her common shares on March 30, 2026, for $36.325 each, a transaction totaling $181,770, according to a Form 4 filed with the SEC. The sale leaves Brown with no holdings and occurs while SLG shares hover near their 52-week low of $34.77. The company recently reported …
UWM Holdings insiders executed three block sales totaling 3,001,722 shares of Class A common stock between March 26 and March 30, 2026, generating roughly $10.4 million. The trades were completed under a 10b5-1 plan adopted by SFS Corp in September 2025. The stock is trading near a 52-week low while UWM navigates recent earnings beats, analyst adju…
Richard L. Markee, a director at Five Below, sold 3,000 shares on March 26, 2026, for $232.04 per share, a transaction totaling $696,120. The sale coincides with the specialty retailer's stock trading near its 52-week high and substantial gains over the past year, while several investment banks have raised their price targets following favorable qu…
Eugene S. Stark, General American Investors Co Inc's VP Administration/CCO/PFO, bought a combined 838 shares of the company's 5.95% Preferred Stock across two transactions on March 27 and March 30, 2026. The purchases totaled $20,902. After the trades, Stark's direct and indirect holdings in the preferred and common shares are detailed below. GAM's…
Edgewise Therapeutics Chief Medical Officer Joanne M. Donovan sold 16,358 shares of company stock on March 27, 2026, generating roughly $506,734 in proceeds from two separate transactions at prices between $30.49 and $31.68. After the sales Donovan retains direct ownership of 9,597 shares. The insider move occurs as EWTX shares trade close to their…
Ashish Bendre, Allient INC's vice president and group president, sold 6,000 shares on March 27, 2026, for $63.00 per share, completing a $378,000 transaction. The sale comes after a 165% one-year jump in the stock that has since retreated to $59.52. Allient also reported a robust fourth quarter for 2025, with EPS and revenue topping forecasts and m…
CME Group Director William R. Shepard purchased $437,101 worth of company stock on March 26, 2026, acquiring shares both directly and through a trust. The transactions occurred near the market price as the derivatives operator reports record open interest in U.S. Treasury products and moves to expand crypto trading hours.
Xilio Therapeutics director Shannon James Samuel purchased 5,000 shares of common stock on March 26, 2026, for a total of $43,949 at a reported price of $8.79 per share. The SEC filing notes transaction prices ranged from $8.6758 to $9.2499. After the purchase, Samuel directly owns 10,000 shares. The transaction occurs while XLO trades at $8.23 and…
Director Jarrod M. Patten sold 700 Class A shares for $96,159 on March 26, 2026, and exercised options to acquire 700 shares the same day. Strategy Inc’s (MSTR) stock has been volatile, and the company temporarily halted weekly bitcoin purchases after a run of buying activity that included roughly 45,000 BTC over the prior 30 days.
A director at ACCESS Newswire Inc. increased his holding by purchasing 1,500 shares on March 25, 2026, for $10,935. The move comes as the stock has climbed more than 20% over the prior week. The company reported a mixed fourth-quarter 2025 with an EPS beat but a slight revenue shortfall, and a financial research platform flags the stock as underval…
